<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Mol Allergy</journal-id><journal-title>Clinical and Molecular Allergy</journal-title><issn pub-type="epub">1476-7961</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1476-7961-4-3</article-id><article-id pub-id-type="pmid">16503977</article-id><article-id pub-id-type="doi">10.1186/1476-7961-4-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>IL-4 alpha chain receptor (IL-4R&#x003b1;) polymorphisms in allergic bronchopulmonary sspergillosis</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Knutsen</surname><given-names>Alan P</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I3">3</xref><email>knutsenm@slu.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Kariuki</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kariukib@slu.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Consolino</surname><given-names>Judy D</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>consoljd@slu.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Warrier</surname><given-names>Manoj R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m_warrier@hotmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Allergy/Immunology, Saint Louis University Health Sciences Center and St. Louis, Missouri, USA</aff><aff id="I2"><label>2</label>Division of Pulomology, Saint Louis University Health Sciences Center, St. Louis, Missouri, USA</aff><aff id="I3"><label>3</label>Professor Pediatrics, Director Allergy &#x00026; Immunology, Pediatric Research Institute, 3662 Park Avenue, St. Louis, MO 63110, USA</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>17</day><month>2</month><year>2006</year></pub-date><volume>4</volume><fpage>3</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www.clinicalmolecularallergy.com/content/4/1/3"/><history><date date-type="received"><day>21</day><month>10</month><year>2005</year></date><date date-type="accepted"><day>17</day><month>2</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Knutsen et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Knutsen et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Knutsen P Alan knutsenm@slu.edu </dc:author><dc:title> IL-4 alpha chain receptor (IL-4R&#x003b1;) polymorphisms in allergic bronchopulmonary sspergillosis </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Clinical and Molecular Allergy 4(1): 3-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-7961(2006)4:1&#x0003c;3&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-7961</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Allergic bronchopulmonary aspergillosis occurs in 7&#x02013;10% of cystic fibrosis (CF) and 1&#x02013;2% of asthmatic patients. HLA-DR restriction and increased sensitivity to IL-4 stimulation have been proposed as risk factors in these populations.</p></sec><sec><title>Objective</title><p>We examined for the presence of IL-4 receptor alpha chain (IL-4R&#x003b1;) single nucleotide polymorphisms (SNPs) in ABPA and whether these accounted for increased sensitivity to IL-4 stimulation.</p></sec><sec sec-type="methods"><title>Methods</title><p>One extracellular (ile75val) and four cytoplasmic IL-4R&#x003b1; SNPs were analyzed in 40 CF and 22 asthmatic patients and in 56 non-ABPA CF and asthmatic patients. Sensitivity to IL-4 stimulation was measured by induction of CD23 expression on B cells.</p></sec><sec><title>Results</title><p>IL-4R&#x003b1; SNPs were observed in 95% of ABPA patients. The predominant IL-4R&#x003b1; SNP was the extracellular IL-4R&#x003b1; SNP, ile75val, observed in 80% of ABPA patients.</p></sec><sec><title>Conclusion</title><p>The presence of IL-4R&#x003b1; SNPs, principally ile75val, appears to be a genetic risk for the development of ABPA.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Allergic bronchopulmonary aspergillosis (ABPA) is a Th2 cell mediated hypersensitivity lung disease due to bronchial colonization with <italic>A. fumigatus </italic>that affects approximately 1&#x02013;2% of asthmatic and 7&#x02013;9% of cystic fibrosis (CF) patients [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The immunologic hallmarks of ABPA are elevated IgE antibodies to <italic>A. fumigatus</italic>, elevated total serum IgE levels, and peripheral blood and bronchial eosinophilia. A sequelae of ABPA is bronchiectasis and/or pulmonary fibrosis which progressively compromises respiratory function increasing morbidity and mortality. Sensitization to <italic>A. fumigatus </italic>is common in asthmatic and CF patients, yet only a small percentage develop ABPA. We hypothesize that ABPA patients have genetic risk factors which predispose for the development of ABPA. Chauhan et al [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>] found that ABPA patients have increased frequency of HLA-DR2 and DR5. However, only a minority of atopic patients with these genotypes develop ABPA.</p><p>In earlier studies, we reported that ABPA patients demonstrated increased sensitivity to IL-4 stimulation as measured by up-regulation of CD23 on their B-cells [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Previous studies have reported that single nucleotide polymorphisms (SNP) of the IL-4 alpha receptor (IL-4R&#x003b1;) is associated with up-regulation of IL-4 stimulation [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B16">16</xref>].</p><p>In this study to explain this observation of increased sensitivity to IL-4 stimulation, we examined IL-4 receptor alpha chain (IL-4R&#x003b1;) single nucleotide polymorphisms (SNP). The frequency of IL-4R&#x003b1; SNPs was present in approximately 95% of ABPA patients, and the predominant SNP was ile75val in the IL-4 binding region. We propose that increased sensitivity to IL-4 in conjunction with HLA-DR2/DR5 restriction to <italic>Aspergillus </italic>antigens in ABPA patients result in increased B-cell activity, monocyte/dendritic cell phenotype that polarizes <italic>Aspergillus</italic>-specific Th2 responses.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>The study population consisted of 40 CF and asthmatic ABPA patients and 56 non-ABPA CF and asthmatic control patients. The study was approved by the Saint Louis University Institutional Review Board. Criteria for ABPA in asthmatic patients are those described previously by Greenberger [<xref ref-type="bibr" rid="B1">1</xref>]. Recently, a Cystic Fibrosis Foundation Consensus Conference proposed diagnostic criteria for the diagnosis of ABPA in CF patients that was used for this study [<xref ref-type="bibr" rid="B2">2</xref>]:</p><p>1. Clinical deterioration (cough, wheeze, exercise intolerance, exercise induced asthma, deterioration of pulmonary function, increased sputum).</p><p>2. Serum IgE level &#x02265;500 IU/ml.</p><p>3. IgE anti-<italic>Aspergillus </italic>antibody. Either immediate cutaneous reactivity to <italic>Aspergillus </italic>or presence of IgE anti-Af antibodies by ELISA.</p><p>4. IgG anti-<italic>Aspergillus </italic>antibody. Either precipitating antibodies to <italic>Aspergillus </italic>or presence of IgG anti-Af antibodies by ELISA.</p><p>5. Abnormal chest radiograph and/or high-resolution computerized tomography (infiltrates, bronchiectasis, plugging, or change from previous radiograph), as read by the radiologist.</p></sec><sec><title>IL-4R&#x003b1; genotyping by PCR with sequence-specific primers and direct sequence analysis</title><p>Genomic variants in IL-4R&#x003b1; gene was identified by direct sequencing using PCR-based method for single nucleotide polymorphism (SNP). Genomic variants of IL-4R&#x003b1; were numbered on the basis of their location in IL-4R&#x003b1; mRNA sequence of gene bank accession number X52425. Five previously reported IL-4R&#x003b1; variants ile75val, glu400ala, cys431arg, ser503pro and gln576arg (numbering including the 25 amino acid signal peptide) were genotyped. Presence of polymorphisms and its allelic variants were determined by direct PCR-SSP protocols with slight modifications [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Genotyping for the ile75val SNP of the IL-4R&#x003b1; gene was determined by PCR amplification. A 755 bp long region of IL-4R&#x003b1; was amplified using the following primers: forward 5' ATGCAGAGCTTATGTTGTTCTA3' and reverse 5' TTCCTCCTGCTGTTGCTATGA3'. PCR reactions for identification of IL-4R&#x003b1; variants glu400ala, cys431arg, ser503leu and gln576arg were conducted by amplifying a 991 bp long fragment using the following primers: forward 5' CTGTTTTCTGGAGCACAACAT 3' and reverse 5' CTTGAGAAGGCCTTGTAACCA 3'. Allele specific primers were used to amplify specific regions of IL-4 receptors containing the alleles of interest using a thermal cycler (Perkin Elmer Model 9700, Cetus, Norwalk, CT) and polymerase (AmpliTaq Gold, Perkin Elmer) as previously described by Bux et al [<xref ref-type="bibr" rid="B18">18</xref>]. Thermal cycling conditions for first PCR amplification of genomic fragments was as follows: Each DNA sample was subjected to 40 cycles of denaturation at 95&#x000b0;C for 45 s, annealed at 60&#x000b0;C for 45 s and extension at 72&#x000b0;C for 90 s. PCR products were visualized on 1% agarose gel with ethidium bromide. A second PCR was performed for direct sequencing of amplified fragments using the Big Dye Terminator Kit (Perkin-Elmer Applied Biosystems, Foster City, CA) and subsequent analysis on a capillary automated sequencer CEQ 2000XL (Beckman Coulter, Fullerton, CA). The presence of IL-4R&#x003b1; nucleotide polymorphisms were examined using the NCBI Blast program (<ext-link ext-link-type="uri" xlink:href="http://ncbi.nlm.nih.gov/blast/bl2seq/wblast2"/>; accession number 33833); homozygous/heterozygous SNPs were detected on the nucleotide chromatograph.</p></sec><sec><title>IL-4 induction of B-cell CD23 expression</title><p>Peripheral blood mononuclear cells (PBMC) were isolated from venous blood by Ficoll-Hypaque density centrifugation as previously described [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. PBMC were cultured at 1 &#x000d7; 10<sup>6 </sup>cells/ml in 1 ml of RPMI 1640 supplemented with 10% FCS for 48 hours at 37&#x000b0;C in a 6% CO<sub>2 </sub>humidified atmosphere. The cultures were stimulated with rhuIL-4 (PeproTech, Inc) at 1, 5, 10 and 25 ng/ml. After 48 hours, the cells were washed and analyzed by flow cytometry.</p></sec><sec><title>Flow cytometry</title><p>PBMC prior to culture and after culture were analyzed for induction of cell surface CD23 expression on B-cells, and T-cells analyzed for induction of cytoplasmic cytokine expression as previously described [<xref ref-type="bibr" rid="B7">7</xref>]. For cultures stimulated with IL-4 and IL-13, PBMC were washed and stained with murine monoclonal antibody to CD23-PE and CD20 Per-CP (Becton Dickinson). PBMCs were washed and fixed with 1% PBS buffered paraformaldehyde. Forward and side-scatter was performed to gate on the live lymphocyte population and further gated on CD20<sup>+ </sup>cells for analysis using the CellQuest MacIntosh program (Becton Dickinson). A minimum of 10,000 cells were counted. Quantibrite PE flow cytometry beads (Becton Dickinson) were used to quantitate the number of CD23 receptors per B-cell for each experiment. The beads contain a given number of PE molecules per bead. A linear equation was calculated from which the number of CD23 receptors per cell was extrapolated, and the total number of CD23 receptors expressed per B-cell expressed.</p></sec><sec><title>Statistics</title><p>Analysis of the frequency of IL-4R&#x003b1; SNPs was analyzed by chi square analysis and used to compare ABPA versus the non-ABPA patients. CD23 expression was analyzed by Student's t-test with unequal variance. Based on the published data, we estimate that there will need to be 30 patients in each group to have a 95% power to detect a mean difference of 9.48%, statistically significant with P value (alpha) = .05 (two-tailed), using GraphPad StatMate software package.</p></sec></sec><sec><title>Results</title><sec><title>Patients</title><p>The demographic characteristics of the patients are presented in Table <xref ref-type="table" rid="T1">1</xref>. There were 14 CF and 26 asthmatic ABPA patients; there were 33 CF and 23 asthmatic non-ABPA patients. The sex distribution was equal in the asthmatic and CF ABPA patients compared to the non-ABPA patients, 65% versus 64%. The demongraphic of the asthmatic and CF ABPA patients was comparable except that asthmatic ABPA patients were older than CF ABPA patients, 41 versus 12 years old, and this also observed for the non-ABPA patients. IgE reactivity to <italic>A. fumigatus </italic>was identified in 100% of ABPA patients and in 41% of non-ABPA patients; IgG reactivity was determined by ELISA assay and was identified in 100% of ABPA and 88% of non-ABPA patients. Serum IgE levels were markedly elevated in ABPA patients compared to non-ABPA patients, 2617 &#x000b1; 2275 versus 87 &#x000b1; 133 IU/ml (P &#x0003c; 0.01).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Demographics of asthmatic and cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Study</bold></td><td align="center"><bold>ABPA (40)</bold></td><td align="center"><bold>Non-ABPA (56)</bold></td></tr></thead><tbody><tr><td align="left">CF</td><td align="center">14 (35%)</td><td align="center">33 (59%)</td></tr><tr><td align="left">Asthma</td><td align="center">26 (65%)</td><td align="center">23 (41%)</td></tr><tr><td align="left">Age, yrs</td><td align="center">24 &#x000b1; 18</td><td align="center">27 &#x000b1; 12</td></tr><tr><td align="left">Sex, % male</td><td align="center">65%</td><td align="center">64%</td></tr><tr><td align="left">IgE, IU/ml</td><td align="center">2617 &#x000b1; 2275</td><td align="center">87 &#x000b1; 133</td></tr><tr><td align="left">Reactivity to <italic>A. fumigatus</italic></td><td></td><td></td></tr><tr><td align="left">&#x02003;Positive Af skin test</td><td align="center">40 (100%)</td><td align="center">23 (41%)</td></tr><tr><td align="left">&#x02003;IgG anti-Af antibody</td><td align="center">40 (100%)</td><td align="center">49 (88%)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: ABPA, allergic bronchopulmonary aspergillosis; CF, cystic fibrosis; Af, <italic>Aspergillus fumigatus</italic>.</p><p>Data presented as number of patients and in parentheses percentage. For age and IgE, data presented as Mean &#x000b1; SD.</p></table-wrap-foot></table-wrap></sec><sec><title>IL-4Ra SNPs</title><p>The frequency of IL-4 R&#x003b1; SNPs was significantly increased in ABPA patients compared to non-ABPA patients, 95% versus 61% (p = 0.0001) (Table <xref ref-type="table" rid="T2">2</xref>). The predominant IL-4R&#x003b1; SNP observed was ile75val in IL-4 binding region. This was observed in 80% of ABPA patients compared to 54% of non-ABPA patients (p = 0.008). The frequencies of IL-4R&#x003b1; SNPs were comparable comparing asthmatic and CF ABPA patients: IL-4R&#x003b1; SNPs 93% and 96% and ile75val 79% and 81%, respectively. Furthermore, the ile75val SNP was homozygous in 43% of ABPA patients compared to 11% of non-ABPA patients (p = 0.0003). An additional extracellular SNP, asn98thr, was identified in a CF ABPA patient as an isolated polymorphism. We previously reported this patient, and this was associated with increased sensitivity to IL-4 stimulation [<xref ref-type="bibr" rid="B19">19</xref>]. One or more cytoplasmic IL-4R&#x003b1; SNPs were observed in 38% of ABPA patients compared to 27% of non-ABPA patients (p = ns). The combination of ile75val and cytoplasmic SNPs were not significantly increased in ABPA patients compared to non-ABPA patients, present in 28% and 21%, respectively.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>IL-4R&#x003b1; single nucleotide polymorphisms in asthmatic and cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Study</bold></td><td align="center" colspan="2"><bold>Number of Patients</bold></td><td align="center"><bold><italic>P*</italic></bold></td></tr><tr><td></td><td align="center"><bold>ABPA (40)</bold></td><td align="center"><bold>Non-ABPA (56)</bold></td><td></td></tr></thead><tbody><tr><td align="left">Extracellular IL-4R&#x003b1; SNPs</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;ile75val</td><td align="center">32 (80%)</td><td align="center">30 (54%)</td><td align="center">0.008</td></tr><tr><td align="left">&#x02003;asn98thr</td><td align="center">2 (5%)</td><td align="center">4 (8%)</td><td align="center">ns</td></tr><tr><td align="left">&#x02003;Homozygous ile75val</td><td align="center">17 (43%)</td><td align="center">6 (11%)</td><td align="center">0.0003</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">Cytoplasmic IL-4R&#x003b1; SNPs</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;glu400ala</td><td align="center">5 (13%)</td><td align="center">3 (5%)</td><td align="center">ns</td></tr><tr><td align="left">&#x02003;cys431arg</td><td align="center">3 (8%)</td><td align="center">4 (7%)</td><td align="center">ns</td></tr><tr><td align="left">&#x02003;ser503pro</td><td align="center">9 (23%)</td><td align="center">10 (18%)</td><td align="center">ns</td></tr><tr><td align="left">&#x02003;gln576arg</td><td align="center">8 (20%)</td><td align="center">14 (25%)</td><td align="center">ns</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left">Any IL-4R&#x003b1; SNP</td><td align="center">38 (95%)</td><td align="center">34 (61%)</td><td align="center">0.0001</td></tr><tr><td align="left">Extracellular and Cytoplasmic IL-4R&#x003b1; SNP</td><td align="center">11 (28%)</td><td align="center">12 (21%)</td><td align="center">ns</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: IL-4R&#x003b1;, interleukin 4 receptor alpha chain; SNP, single nucleotide polymorphism; ABPA, allergic bronchopulmonary aspergillosis; ns, not significant.</p><p>In parentheses, percentage (%) of patients.</p><p>* Chi square analysis comparing ABPA versus Non-ABPA patients.</p></table-wrap-foot></table-wrap></sec><sec><title>Up-regulation of CD23 by IL-4 stimulation</title><p>The up-regulation of CD23 molecules on B-cells by IL-4 stimulation is shown in Figure <xref ref-type="fig" rid="F1">1</xref>. In the absence of IL-4, the number of CD23 molecules decreased after 48 hours in media and was comparable in both groups. With IL-4 stimulation, the slope of increased number of CD23 molecules per B-cell was significantly greater in ABPA patients compared to non-ABPA patients (p &#x0003c; 0.01). Furthermore, the number of CD23 molecules per B-cell was increased in ABPA patients at IL-4 concentrations of 1 ng/ml, 5 ng/ml and 10 ng/ml. Up-regulation of CD23 expression was observed for each of the IL-4R&#x003b1; SNPs.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><italic>IL-4 induction </italic>of <italic>CD23+ molecules on CD20+B-cells</italic>. Following IL-4 stimulation, ABPA patients had a significantly increased rate of CD23+ expression per B-cell compared to non-ABPA patients at 5 ng/ml and 10 ng/ml (p &#x0003c; 0.02*, &#x0003c; 0.02*). Data presented as Mean &#x000b1; SE.</p></caption><graphic xlink:href="1476-7961-4-3-1"/></fig></sec></sec><sec><title>Discussion</title><p>A key question in the development of ABPA in CF and asthmatic patients is why do only 1&#x02013;2% and 7&#x02013;9% of this at risk population develop ABPA. Chauhan et al [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>] observed that patients with asthma and CF who expressed HLA-DR2 and/or DR5 (and perhaps HLA-DR4 or DR7) but lacked HLA-DQ2 were at increased risk for ABPA after exposure to <italic>A. fumigatus</italic>. Within HLA-DR2 and HLA-DR5, restricted genotypes, in particular, HLA-DR2 B1*1501 and 1503 and HLA-DR5 B1*1101 and B1*1103, provide high relative risk. On the other hand, 40% to 44% of non-ABPA atopic <italic>Aspergillus</italic>-sensitive individuals have the HLA-DR2 and/or DR5 type. These results demonstrating HLA-DR restriction are similar to those found with purified house dust mite allergens [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. Thus, certain genotypes of HLA-DR2 and DR5 may be necessary but not sufficient to cause ABPA. Furthermore, Chauhan et al [<xref ref-type="bibr" rid="B4">4</xref>] demonstrated that Asp f l allergen has a low-affinity of binding to HLA-DR. This is consistent with Th2 T cell response previously reported by others in that strong antigen HLA-DR-Ag-TCR affinity binding favored a Th1 cellular response whereas low affinity binding favored a Th2 humoral response [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. Thus, we propose that antigen presenting cells bearing HLA-DR2/DR5 and with increased sensitivity to IL-4 stimulation may play a critical role in skewing the Th2 responses to <italic>A. fumigatus </italic>in ABPA.</p><p>We previously reported that in ABPA patients there was significant up-regulation of CD23 expression of IL-4 stimulated peripheral blood mononuclear cells [<xref ref-type="bibr" rid="B7">7</xref>]. Other investigators have identified IL-4R&#x003b1; single nucleotide polymorphisms (SNP) that result in a gain-of-function of IL-4 stimulation [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. We examined one extracellular and four cytoplasmic SNPs. In these studies, we observed IL-4R&#x003b1; SNPs in 95% of ABPA patients. The extracellular IL-4 binding SNP, ile75val, was the most frequently identified SNP and was frequently homozygous. Hershey's group reported that the combination of two variants, ile75val and gln576arg, together resulted in elevated IL-4 dependent CD23 expression and risk of atopy and asthma severity which was not observed when these SNPs were present alone [<xref ref-type="bibr" rid="B16">16</xref>]. However, we observed the combination of ile75val and a cytoplasmic IL-4R&#x003b1; SNP in only 28% of ABPA patients.</p><p>Other genetic risk factors have been proposed for the development of atopy, asthma and ABPA. In particular, in the development of increased asthma severity, investigators have reported that another combination of the ile75val IL-4R&#x003b1; SNP and arg110gln IL-13 SNP has also been associated with allergy and asthma [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. We have recently begum studies to examine the IL-13 SNP. Saxena et al [<xref ref-type="bibr" rid="B28">28</xref>] reported that ABPA patients with polymorphisms (ala91pro, arg94arg) in the collagen region of pulmonary surfactant protein A2 (SP-A2) had more elevated total IgE levels and higher percentages of eosinophilia than those observed in patients who lacked the SNPs. They also found that 80% of patients carrying both alleles had ABPA (P = 0.0079, OR = 10.4), while only 50% and 60% of patients carrying each allele, individually, were ABPA subjects, suggesting an additive effect.</p><p>IL-10 may also play a significant role in the development of atopy and ABPA. In previous studies, we observed increased IL-10 and IL-5 synthesis of Asp f2, f3 and f4 stimulated peripheral blood lymphocytes in CF and asthmatic ABPA patients [<xref ref-type="bibr" rid="B7">7</xref>]. Polymorphisms of the IL-10 promoter have been associated with risk of asthma [<xref ref-type="bibr" rid="B29">29</xref>] and ABPA [<xref ref-type="bibr" rid="B30">30</xref>]. In particular, Brourad et al [<xref ref-type="bibr" rid="B30">30</xref>] reported the association of the -1082GG genotype of IL-10 promoter and the colonization with <italic>A. fumigatus </italic>and the development of ABPA in CF. The -10822G polymorphism has been associated with increased IL-10 synthesis; whereas the -1082A allele has lower IL-10 synthesis. These investigators reported that 23&#x02013;25% of CF patients were -1082GG, 49&#x02013;53% -1082AG, and 24&#x02013;26% -1082AA. There was significantly increased risk to become colonized with <italic>A. fumigatus </italic>and to develop ABPA in the -1082GG genotype group, which developed in 7% of the patients. Thus, one may hypothesize that antigen presenting cells (dendritic cells) expressing HLA-DR2/DR5 with increased IL-10 synthesis and increased sensitivity to IL-4 stimulation due to IL-4R&#x003b1; polymorphisms may be responsible for driving an allergic inflammatory response to <italic>A. fumigatus </italic>in ABPA.</p><p>The major limitation of this study is the small numbers of ABPA patients studied. However, the frequency of IL-4R&#x003b1; polymorphisms is so prevalent, further studies will likely confirm this preliminary study.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>APK conceived of the study, participated in its design and coordination, and drafted the manuscript; BK participated in the molecular genetic studies; JDC was instrumental in providing patient samples; and MRW participated in the molecular genetic studies. All authors read and approved of the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors appreciate the willing participation of the patients who participated in this study. The study was funded by grants from the Cystic Fibrosis Foundation.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Greenberger</surname><given-names>PA</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Adkinson NF Jr, Yunginer JW, Busse WW, Bochner BS, Holgate ST, Simons FER</surname></name></person-group><article-title>Allergic bronchopulmonary aspergillosis</article-title><source>Allergy: Principles and Practice</source><year>2003</year><publisher-name>Mosby, St. Louis</publisher-name><fpage>1353</fpage><lpage>1371</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>DA</given-names></name><name><surname>Moss</surname><given-names>R</given-names></name><name><surname>Kurup</surname><given-names>VP</given-names></name><name><surname>Knutsen</surname><given-names>AP</given-names></name><name><surname>Greenberger</surname><given-names>P</given-names></name><name><surname>Judson</surname><given-names>MA</given-names></name><name><surname>Denning</surname><given-names>DW</given-names></name><name><surname>Crameri</surname><given-names>R</given-names></name><name><surname>Brody</surname><given-names>A</given-names></name><name><surname>Light</surname><given-names>M</given-names></name><name><surname>Skov</surname><given-names>M</given-names></name><name><surname>Maish</surname><given-names>W</given-names></name><name><surname>Mastella</surname><given-names>G</given-names></name><collab>the Cystic Fibrosis Foundation Consensus Conference</collab></person-group><article-title>Allergic bronchopulmonary aspergillosis in cystic fibrosis: Cystic Fibrosis Foundation Consensus Conference</article-title><source>Clin Infect Dis</source><year>2003</year><volume>37</volume><fpage>S225</fpage><lpage>S264</lpage><pub-id pub-id-type="pmid">12975753</pub-id><pub-id pub-id-type="doi">10.1086/376525</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>B</given-names></name><name><surname>Santiago</surname><given-names>L</given-names></name><name><surname>Hutcheson</surname><given-names>PS</given-names></name><name><surname>Schwartz</surname><given-names>HJ</given-names></name><name><surname>Spitznagel</surname><given-names>E</given-names></name><name><surname>Castro</surname><given-names>M</given-names></name><name><surname>Slavin</surname><given-names>RG</given-names></name><name><surname>Bellone</surname><given-names>CJ</given-names></name></person-group><article-title>Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis</article-title><source>J Allergy Clin Immunol</source><year>2000</year><volume>106</volume><fpage>723</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">11031343</pub-id><pub-id pub-id-type="doi">10.1067/mai.2000.109913</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>B</given-names></name><name><surname>Santiago</surname><given-names>L</given-names></name><name><surname>Kirschmann</surname><given-names>DA</given-names></name><name><surname>Hauptfeld</surname><given-names>V</given-names></name><name><surname>Knutsen</surname><given-names>AP</given-names></name><name><surname>Hutcheson</surname><given-names>PS</given-names></name><name><surname>Woulfe</surname><given-names>SL</given-names></name><name><surname>Slavin</surname><given-names>RG</given-names></name><name><surname>Schwartz</surname><given-names>HJ</given-names></name><name><surname>Bellone</surname><given-names>CJ</given-names></name></person-group><article-title>The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>4072</fpage><lpage>4076</lpage><pub-id pub-id-type="pmid">9378997</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>BA</given-names></name><name><surname>Knutsen</surname><given-names>AP</given-names></name><name><surname>Hutcheson</surname><given-names>PS</given-names></name><name><surname>Slavin</surname><given-names>RG</given-names></name><name><surname>Bellone</surname><given-names>CJ</given-names></name></person-group><article-title>T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis</article-title><source>J Clin Invest</source><year>1996</year><volume>97</volume><fpage>2324</fpage><lpage>2331</lpage><pub-id pub-id-type="pmid">8636413</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SP</given-names></name><name><surname>McClellan</surname><given-names>JS</given-names></name><name><surname>Knutsen</surname><given-names>AP</given-names></name></person-group><article-title>Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis and atopy</article-title><source>Inter Arch Allergy Immunol</source><year>2000</year><volume>123</volume><fpage>319</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1159/000053644</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knutsen</surname><given-names>AP</given-names></name><name><surname>Hutcheson</surname><given-names>PS</given-names></name><name><surname>Albers</surname><given-names>GM</given-names></name><name><surname>Consolino</surname><given-names>J</given-names></name><name><surname>Smick</surname><given-names>J</given-names></name><name><surname>Kurup</surname><given-names>VP</given-names></name></person-group><article-title>Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis</article-title><source>Allergy</source><year>2004</year><volume>58</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">14674938</pub-id><pub-id pub-id-type="doi">10.1046/j.1398-9995.2003.00129.x</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>GKK</given-names></name><name><surname>Friedrich</surname><given-names>MF</given-names></name><name><surname>Esswein</surname><given-names>LA</given-names></name><name><surname>Thomas</surname><given-names>ML</given-names></name><name><surname>Chatila</surname><given-names>TA</given-names></name></person-group><article-title>Association of atopy with a gain-of-function mutation in the interleukin-4 receptor a chain</article-title><source>N Engl J Med</source><year>1997</year><volume>337</volume><fpage>1720</fpage><lpage>1725</lpage><pub-id pub-id-type="pmid">9392697</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199712113372403</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitsuyasu</surname><given-names>H</given-names></name><name><surname>Izuhara</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>XQ</given-names></name><name><surname>Gao</surname><given-names>PS</given-names></name><name><surname>Arinobu</surname><given-names>Y</given-names></name><name><surname>Enomoto</surname><given-names>T</given-names></name><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Dake</surname><given-names>Y</given-names></name><name><surname>Hamasaki</surname><given-names>N</given-names></name><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name></person-group><article-title>Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma</article-title><source>Nat Genet</source><year>1998</year><volume>19</volume><fpage>119</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">9620765</pub-id><pub-id pub-id-type="doi">10.1038/472</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deichmann</surname><given-names>K</given-names></name><name><surname>Bardutsky</surname><given-names>J</given-names></name><name><surname>Forster</surname><given-names>J</given-names></name><name><surname>Heinzmann</surname><given-names>A</given-names></name><name><surname>Kuehr</surname><given-names>J</given-names></name></person-group><article-title>Common polymorphisms in the coding part of the IL-4 receptor gene</article-title><source>Biochim Biophys Acta</source><year>1997</year><volume>231</volume><fpage>696</fpage><lpage>697</lpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kruse</surname><given-names>S</given-names></name><name><surname>Japha</surname><given-names>T</given-names></name><name><surname>Tedner</surname><given-names>M</given-names></name><name><surname>Sparholt</surname><given-names>SH</given-names></name><name><surname>Forster</surname><given-names>J</given-names></name><name><surname>Kuehr</surname><given-names>J</given-names></name><name><surname>Deichmann</surname><given-names>KA</given-names></name></person-group><article-title>The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction</article-title><source>Immunology</source><year>1999</year><volume>96</volume><fpage>265</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00705.x</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ober</surname><given-names>C</given-names></name><name><surname>Leavitt</surname><given-names>SA</given-names></name><name><surname>Tsalenko</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>TD</given-names></name><name><surname>Hoki</surname><given-names>DM</given-names></name><name><surname>Daniel</surname><given-names>R</given-names></name><name><surname>Newman</surname><given-names>DL</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Parry</surname><given-names>R</given-names></name><name><surname>Lester</surname><given-names>LA</given-names></name><name><surname>Solway</surname><given-names>J</given-names></name><name><surname>Blumenthal</surname><given-names>M</given-names></name><name><surname>King</surname><given-names>RA</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Meyers</surname><given-names>DA</given-names></name><name><surname>Bleecker</surname><given-names>ER</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name></person-group><article-title>Variation in the interleukin-4 receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations</article-title><source>Am J Hum Genet</source><year>2000</year><volume>66</volume><fpage>517</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">10677312</pub-id><pub-id pub-id-type="doi">10.1086/302781</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wjst</surname><given-names>M</given-names></name><name><surname>Kruse</surname><given-names>S</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Deichmann</surname><given-names>K</given-names></name></person-group><article-title>Asthma and IL-4 receptor alpha gene variants</article-title><source>Eur J Immunogenetics</source><year>2002</year><volume>29</volume><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">12047364</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2370.2002.00300.x</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosa-Rosa</surname><given-names>L</given-names></name><name><surname>Zimmermann</surname><given-names>N</given-names></name><name><surname>Bernstein</surname><given-names>JA</given-names></name><name><surname>Rothenberg</surname><given-names>ME</given-names></name><name><surname>Khurana Hershey</surname><given-names>GK</given-names></name></person-group><article-title>The R576 IL-4 receptor alpha allele correlates with asthma severity</article-title><source>J Allergy Clin Immunol</source><year>1999</year><volume>104</volume><fpage>1008</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">10550746</pub-id><pub-id pub-id-type="doi">10.1016/S0091-6749(99)70082-5</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitsuyasu</surname><given-names>H</given-names></name><name><surname>Yanagihara</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Arinobu</surname><given-names>Y</given-names></name><name><surname>Ihara</surname><given-names>K</given-names></name><name><surname>Takabayashi</surname><given-names>A</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Enomoto</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Hamasaki</surname><given-names>N</given-names></name><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name><name><surname>Izuhara</surname><given-names>K</given-names></name></person-group><article-title>Cutting edge: Dominant effect of Ile50Val variant of the human IL-4 receptor &#x003b1;-chain in IgE synthesis</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">9973373</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Risma</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Andrews</surname><given-names>RP</given-names></name><name><surname>Cunningham</surname><given-names>CM</given-names></name><name><surname>Ericksen</surname><given-names>MB</given-names></name><name><surname>Bernstein</surname><given-names>JA</given-names></name><name><surname>Chakraborty</surname><given-names>R</given-names></name><name><surname>Hershey</surname><given-names>GK</given-names></name></person-group><article-title>V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>1604</fpage><lpage>1610</lpage><pub-id pub-id-type="pmid">12133990</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hackstein</surname><given-names>H</given-names></name><name><surname>Kluter</surname><given-names>H</given-names></name><name><surname>Fricke</surname><given-names>L</given-names></name><name><surname>Hoyer</surname><given-names>J</given-names></name><name><surname>Bein</surname><given-names>G</given-names></name></person-group><article-title>The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival</article-title><source>Tissue Antigens</source><year>1999</year><volume>54</volume><fpage>471</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">10599886</pub-id><pub-id pub-id-type="doi">10.1034/j.1399-0039.1999.540504.x</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bux</surname><given-names>J</given-names></name><name><surname>Stein</surname><given-names>EL</given-names></name><name><surname>Bierling</surname><given-names>P</given-names></name><name><surname>Fromont</surname><given-names>P</given-names></name><name><surname>Clay</surname><given-names>M</given-names></name><name><surname>Stroncel</surname><given-names>D</given-names></name><name><surname>Santoso</surname><given-names>S</given-names></name></person-group><article-title>Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb</article-title><source>Blood</source><year>1997</year><volume>89</volume><fpage>1027</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">9028335</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knutsen</surname><given-names>AP</given-names></name><name><surname>Warrier</surname><given-names>MR</given-names></name><name><surname>Noyes</surname><given-names>B</given-names></name><name><surname>Consolino</surname><given-names>J</given-names></name></person-group><article-title>Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is &#x0003c;500 IU/ml</article-title><source>Ann Allergy Asthma Immunol</source><year>2005</year><comment></comment><pub-id pub-id-type="pmid">16312174</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verhoef</surname><given-names>A</given-names></name><name><surname>Higgins</surname><given-names>JA</given-names></name><name><surname>Thorpe</surname><given-names>CJ</given-names></name><name><surname>Marsh</surname><given-names>SG</given-names></name><name><surname>Hayball</surname><given-names>JD</given-names></name><name><surname>Lamb</surname><given-names>JR</given-names></name><name><surname>O'Hehir</surname><given-names>RE</given-names></name></person-group><article-title>Clonal analysis of the atopic immune response to the group 2 allergen of Dermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes</article-title><source>Inter Immunol</source><year>1993</year><volume>5</volume><fpage>1589</fpage><lpage>1597</lpage></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>JR</given-names></name><name><surname>Higgins</surname><given-names>JA</given-names></name><name><surname>Hetzel</surname><given-names>C</given-names></name><name><surname>Hayball</surname><given-names>JD</given-names></name><name><surname>Lake</surname><given-names>RA</given-names></name><name><surname>O'Hehir</surname><given-names>RE</given-names></name></person-group><article-title>The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function</article-title><source>Immunol</source><year>1995</year><volume>85</volume><fpage>447</fpage><lpage>454</lpage></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsitoura</surname><given-names>DC</given-names></name><name><surname>Verhoef</surname><given-names>A</given-names></name><name><surname>Gelder</surname><given-names>CM</given-names></name><name><surname>O'Hehir</surname><given-names>RE</given-names></name><name><surname>Lamb</surname><given-names>JR</given-names></name></person-group><article-title>Altered T cell ligands derived from a major house dust mite allergen enhance IFN-&#x003b3; but not IL-4 production by human CD4<sup>+ </sup>T cells</article-title><source>J Immunol</source><year>1996</year><volume>157</volume><fpage>2160</fpage><lpage>2165</lpage><pub-id pub-id-type="pmid">8757342</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>C</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Southwood</surname><given-names>S</given-names></name><name><surname>Ketelaar</surname><given-names>H</given-names></name><name><surname>Sette</surname><given-names>A</given-names></name><name><surname>Bottomly</surname><given-names>K</given-names></name></person-group><article-title>Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo</article-title><source>J Exp Med</source><year>1995</year><volume>181</volume><fpage>1569</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">7699337</pub-id><pub-id pub-id-type="doi">10.1084/jem.181.4.1569</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evavold</surname><given-names>BD</given-names></name><name><surname>Sloan-Lancaster</surname><given-names>J</given-names></name><name><surname>Hsu</surname><given-names>BL</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name></person-group><article-title>Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides</article-title><source>J Immunol</source><year>1993</year><volume>150</volume><fpage>3131</fpage><lpage>3140</lpage><pub-id pub-id-type="pmid">8468461</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Racioppi</surname><given-names>L</given-names></name><name><surname>Ronchese</surname><given-names>F</given-names></name><name><surname>Matis</surname><given-names>LA</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><article-title>Peptide-major histocompatibility complex class II complexes with agonist/antagonist properties provide evidence for ligand related differences in T cell receptor dependent intracellular signaling</article-title><source>J Exp Med</source><year>1993</year><volume>177</volume><fpage>1047</fpage><lpage>1060</lpage><pub-id pub-id-type="pmid">8384651</pub-id><pub-id pub-id-type="doi">10.1084/jem.177.4.1047</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Ericksen</surname><given-names>MB</given-names></name><name><surname>Hershey</surname><given-names>GKK</given-names></name></person-group><article-title>Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants</article-title><source>J Allergy Clin Immuno</source><year>2004</year><volume>114</volume><fpage>553</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2004.04.044</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vladich</surname><given-names>FD</given-names></name><name><surname>Brazille</surname><given-names>SM</given-names></name><name><surname>Stern</surname><given-names>D</given-names></name><name><surname>Peck</surname><given-names>ML</given-names></name><name><surname>Ghittoni</surname><given-names>R</given-names></name><name><surname>Vercelli</surname><given-names>D</given-names></name></person-group><article-title>IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>747</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">15711639</pub-id><pub-id pub-id-type="doi">10.1172/JCI200522818</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Madan</surname><given-names>T</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Muralidhar</surname><given-names>K</given-names></name><name><surname>Sarma</surname><given-names>PA</given-names></name></person-group><article-title>Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis</article-title><source>J Allergy Clin Immunol</source><year>2003</year><volume>111</volume><fpage>1001</fpage><lpage>1007</lpage><pub-id pub-id-type="pmid">12743564</pub-id><pub-id pub-id-type="doi">10.1067/mai.2003.1395</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karjalainen</surname><given-names>J</given-names></name><name><surname>Hulkkonen</surname><given-names>J</given-names></name><name><surname>Nieminen</surname><given-names>MM</given-names></name><name><surname>Huhtala</surname><given-names>H</given-names></name><name><surname>Aromaa</surname><given-names>A</given-names></name><name><surname>Klaukka</surname><given-names>T</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma</article-title><source>Clin Exp Allergy</source><year>2003</year><volume>33</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">12534553</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2222.2003.01577.x</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brouard</surname><given-names>J</given-names></name><name><surname>Knauer</surname><given-names>N</given-names></name><name><surname>Boelle</surname><given-names>P-Y</given-names></name><name><surname>Corvol</surname><given-names>H</given-names></name><name><surname>Henrion-Caude</surname><given-names>A</given-names></name><name><surname>Flamant</surname><given-names>C</given-names></name><name><surname>Bremont</surname><given-names>F</given-names></name><name><surname>Delaisi</surname><given-names>B</given-names></name><name><surname>Duhamel</surname><given-names>J-F</given-names></name><name><surname>Marguet</surname><given-names>C</given-names></name><name><surname>Roussey</surname><given-names>M</given-names></name><name><surname>Miesch</surname><given-names>M-C</given-names></name><name><surname>Chadelat</surname><given-names>K</given-names></name><name><surname>Boule</surname><given-names>M</given-names></name><name><surname>Fauroux</surname><given-names>B</given-names></name><name><surname>Ratjen</surname><given-names>F</given-names></name><name><surname>Grasemann</surname><given-names>H</given-names></name><name><surname>Clement</surname><given-names>A</given-names></name></person-group><article-title>Influence of interleukin-10 on airways colonization by Aspergillus fumigatus in cystic fibrosis patients</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>1988</fpage><lpage>1991</lpage><pub-id pub-id-type="pmid">15871134</pub-id><pub-id pub-id-type="doi">10.1086/429964</pub-id></citation></ref></ref-list></back></article> 